Supporting and Maintaining a Surveillance System for Chronic Kidney Disease (CKD) in the United States

 

This program will build upon previous work to continue developing, supporting and enhancing the Chronic Kidney Disease (CKD) Surveillance System in the United States, to monitor the burden and trends of CKD and its risk factors over time, and monitor and evaluate trends in achieving Healthy People 2030 objectives.

Active 93.833 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. Section 317(k)(2) of the Public Health Service Act (PHS Act), 42 U.S.C. 247b(k)(2), Section 301(a) of the PHS Act, 42 U.S.C. 241(a). o Public nonprofit organizations o Private nonprofit organizations o For profit organizations o Small, minority, and women-owned businesses o Universities o Colleges o Research institutions o Hospitals o Community-based organizations o Faith-based organizations o Indian/Native American Tribal Governments (Federally Recognized) o Indian/Native American Tribal Governments (other than Federally recognized) o Indian/Native American Tribally Designated Organizations State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau). Note: A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. The general public will benefit from the objectives of this program. Kidney diseases are the ninth leading cause of death in the United States and more than 1 of 10 US adults may have Chronic Kidney Disease (CKD). The CKD Surveillance System is intended to raise awareness about CKD and its risk factors, promote early diagnosis, and improve outcomes for those living with CKD. Any required credentials and/or documentation will be identified in the specific Notice of Funding Opportunity (NOFO) for this Assistance Listing. Preapplication coordination is required. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any. Contact the headquarters or regional location, as appropriate for application deadlines From 120 to 180 days. Not applicable. From 90 to 120 days. Cooperative agreement period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government. Eligible applicants must be able to demonstrate: -Previous experience with the development of large-scale Chronic Kidney Disease (CKD) surveillance systems -Established and current data sharing and access agreements with appropriate federal, public and private partners for access to data relevant to the CKD surveillance system -A proven track record of publications related to the establishment of a national CKD surveillance system and dissemination of surveillance findings. -Previous experience with national, regional, and hospital based data pertaining to CKD and its risk factors -Previous experience with working in a collaborative multi-center project for the development and maintenance of a national surveillance system. Applicants must adhere to all Centers for Disease Control and Prevention (CDC) guidelines regarding allowable and unallowable expenses. Maintain and enhance a viable and functional Chronic Kidney Disease (CKD) Surveillance System website - www.cdc.gov/ckd/surveillance. Increase the visibility of the CKD Surveillance System and disseminate the CKD surveillance findings by the number of publications and related citations in peer-reviewed journals and presentations at national and international meetings and conferences. Improve the breadth and scope of CKD surveillance data in the United States by the number of established and current data sharing and access agreements with appropriate federal, public and private partners for access to data relevant to CKD surveillance. Expand and grow the CKD Surveillance System by the number of CKD topics and indicators focusing on CKD burden and health consequences, risk factors, at-risk or vulnerable populations, and geographic indicators with up-to-date data and trends. Assess and evaluate the CKD Surveillance System content, data sources to keep or include, gaps in surveillance data, and future data and research needs. Provide data analysis reports for Healthy People 2030 progress review in achieving CKD objectives. Performance Reports: Annual Federal Financial Reports (FFR) and performance/progress reports are required. Final FFRs and performance reports are required. Other reporting may be required and will be outlined in the NOFO or the Notice of Award. Not applicable. In accordance with 2 CFR ?200, as codified in 45 CFR ?75, there is a 3-year record retention requirement; records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with HHS Grants Policy Statement requirements. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient. Notice of Award None/Not specified. Sheryl Heard
4770 Buford Hwy, NE
Atlanta, GA 30341 US
slh3@cdc.gov
Phone: 7704882855 http://www.cdc.gov 75-0943-0-1-550 (Cooperative Agreements) FY 22$1,300,000.00; FY 23 est $1,200,000.00; FY 24 est $1,200,000.00; FY 21$1,200,000.00; FY 20$1,286,288.00; FY 19$1,350,455.00; FY 18$1,311,429.00; FY 17$1,200,000.00; FY 16$1,198,444.00; - Awards range from $200,000 - $400,000 Successful applicants must comply with the administrative requirements outlined in 45 Code of Federal Regulations (CFR) Part 75. Not applicable.